Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease

Neurobiology of Aging

Volumn 43, Issue , 2016, Pages 47-57

  Vandal, Milene ^a,b   White, Philip J ^a,c,d   Tournissac, Marine ^a,b   Tremblay, Cyntia ^b   St Amour, Isabelle ^a,b,e   Drouin Ouellet, Janelle ^a,f   Bousquet, Melanie ^a,b   Traversy, Marie Thérèse ^a,b   Planel, Emmanuel ^a,b   Marette, Andre ^a,d   Calon, Frederic ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LAVAL UNIVERSITY   (Canada)

^e HÉMA QUÉBEC   (Canada)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

3 Tg AD; Alzheimer's disease; Cold exposure; Thermogenesis; Thermoneutrality

Indexed keywords

AMYLOID BETA PROTEIN; NORADRENALIN; TAU PROTEIN; UNCOUPLING PROTEIN 1;

AGE; AGED; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL BODY TEMPERATURE; BRAIN CORTEX; BROWN ADIPOSE TISSUE; COLD EXPOSURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MARKER; FEMALE; MALE; MEMORY; MOUSE; NONHUMAN; NONSHIVERING THERMOGENIC ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SYNAPSE; THERMONEUTRALITY; THERMOREGULATION; TRANSGENIC MOUSE; ADVERSE EFFECTS; ANIMAL; BODY TEMPERATURE; COLD; DISEASE MODEL; ENERGY METABOLISM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TEMPERATURE; THERMOGENESIS;

ADIPOSE TISSUE, BROWN; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BODY TEMPERATURE; BODY TEMPERATURE REGULATION; COLD TEMPERATURE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; MICE, TRANSGENIC; NOREPINEPHRINE; PHOSPHORYLATION; SYNAPSES; TAU PROTEINS; TEMPERATURE; THERMOGENESIS; UNCOUPLING PROTEIN 1;

EID: 84964317452     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.03.024     Document Type: Article

References (109)

1. Akirav I., Sandi C., Richter-Levin G. Differential activation of hippocampus and amygdala following spatial learning under stress. Eur. J. Neurosci. 2001, 14:719-725.
2. 2014 Alzheimer's disease facts and figures. Alzheimers Dement. 2014, 10:e47-e92. Alzheimer Association.
3. Arendt T. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 2009, 118:167-179.
4. Arendt T., Bullmann T. Neuronal plasticity in hibernation and the proposed role of the microtubule-associated protein tau as a "master switch" regulating synaptic gain in neuronal networks. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 305:R478-R489.
5. Arsenault D., Julien C., Tremblay C., Calon F. DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS One 2011, 6:e17397.
6. Bartness T.J., Vaughan C.H., Song C.K. Sympathetic and sensory innervation of brown adipose tissue. Int. J. Obes. (Lond) 2010, 34 Suppl 1:S36-S42.
7. Bell R.D., Sagare A.P., Friedman A.E., Bedi G.S., Holtzman D.M., Deane R., Zlokovic B.V. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab. 2007, 27:909-918.
8. Boncristiano S., Calhoun M.E., Howard V., Bondolfi L., Kaeser S.A., Wiederhold K.H., Staufenbiel M., Jucker M. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice. Neurobiol. Aging 2005, 26:607-613.
9. Bories C., Guitton M.J., Julien C., Tremblay C., Vandal M., Msaid M., De Koninck Y., Calon F. Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease. PLoS One 2012, 7:e46111.
10. Bousquet M., Gue K., Emond V., Julien P., Kang J.X., Cicchetti F., Calon F. Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease. J. Lipid Res. 2011, 52:263-271.
11. Brion J.P., Couck A.M., Passareiro E., Flament-Durand J. Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study. J. Submicrosc. Cytol. 1985, 17:89-96.
12. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 2000, 33:95-130.
13. Cabanac A., Briese E. Handling elevates the colonic temperature of mice. Physiol. Behav. 1992, 51:95-98.
14. Callahan L.M., Vaules W.A., Coleman P.D. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 1999, 58:275-287.
15. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., Rostaing P., Triller A., Salem N.J., Ashe K.H., Frautschy S.A., Cole G.M. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004, 43:633-645.
16. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 2004, 84:277-359.
17. Cannon B., Nedergaard J. Nonshivering thermogenesis and its adequate measurement in metabolic studies. J. Exp. Biol. 2011, 214:242-253.
18. Counts S.E., He B., Nadeem M., Wuu J., Scheff S.W., Mufson E.J. Hippocampal drebrin loss in mild cognitive impairment. Neurodegener. Dis. 2012, 10:216-219.
19. Cunnane S., Nugent S., Roy M., Courchesne-Loyer A., Croteau E., Tremblay S., Castellano A., Pifferi F., Bocti C., Paquet N., Begdouri H., Bentourkia M., Turcotte E., Allard M., Barberger-Gateau P., Fulop T., Rapoport S.I. Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 2011, 27:3-20.
20. Davies C.A., Mann D.M., Sumpter P.Q., Yates P.O. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci. 1987, 78:151-164.
21. Deane R., Bell R.D., Sagare A., Zlokovic B.V. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 2009, 8:16-30.
22. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 2003, 9:907-913.
23. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 1990, 27:457-464.
24. Delacourte A., Defossez A. Alzheimer's disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J. Neurol. Sci. 1986, 76:173-186.
25. Dulloo A.G. The search for compounds that stimulate thermogenesis in obesity management: from pharmaceuticals to functional food ingredients. Obes. Rev. 2011, 12:866-883.
26. Elmarzouki H., Aboussaleh Y., Bitiktas S., Suer C., Artis A.S., Dolu N., Ahami A. Effects of cold exposure on behavioral and electrophysiological parameters related with hippocampal function in rats. Front. Cell. Neurosci. 2014, 8:253.
27. Espana J., Gimenez-Llort L., Valero J., Minano A., Rabano A., Rodriguez-Alvarez J., LaFerla F.M., Saura C.A. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice. Biol. Psychiatry 2010, 67:513-521.
28. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., Eckman C.B., Tanzi R.E., Selkoe D.J., Guenette S. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4162-4167.
29. Festuccia W.T., Blanchard P.G., Richard D., Deshaies Y. Basal adrenergic tone is required for maximal stimulation of rat brown adipose tissue UCP1 expression by chronic PPAR-gamma activation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R159-R167.
30. Filali M., Lalonde R., Theriault P., Julien C., Calon F., Planel E. Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav. Brain Res. 2012, 234:334-342.
31. Fox R.H., Woodward P.M., Exton-Smith A.N., Green M.F., Donnison D.V., Wicks M.H. Body temperatures in the elderly: a national study of physiological, social, and environmental conditions. Br. Med. J. 1973, 1:200-206.
32. Frisard M.I., Broussard A., Davies S.S., Roberts L.J., Rood J., de Jonge L., Fang X., Jazwinski S.M., Deutsch W.A., Ravussin E. Aging, resting metabolic rate, and oxidative damage: results from the Louisiana Healthy Aging Study. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:752-759.
33. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991, 349:704-706.
34. Golozoubova V., Hohtola E., Matthias A., Jacobsson A., Cannon B., Nedergaard J. Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold. FASEB J. 2001, 15:2048-2050.
35. Gomolin I.H., Aung M.M., Wolf-Klein G., Auerbach C. Older is colder: temperature range and variation in older people. J. Am. Geriatr. Soc. 2005, 53:2170-2172.
36. Gordon C.J. Twenty-four hour rhythms of selected ambient temperature in rat and hamster. Physiol. Behav. 1993, 53:257-263.
37. Gordon C.J., Leon L.R. Thermal stress and the physiological response to environmental toxicants. Rev. Environ. Health 2005, 20:235-263.
38. Grandl J., Kim S.E., Uzzell V., Bursulaya B., Petrus M., Bandell M., Patapoutian A. Temperature-induced opening of TRPV1 ion channel is stabilized by the pore domain. Nat. Neurosci. 2010, 13:708-714.
39. Green K.N., Steffan J.S., Martinez-Coria H., Sun X., Schreiber S.S., Thompson L.M., LaFerla F.M. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J. Neurosci. 2008, 28:11500-11510.
40. Greenberg S.G., Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:5827-5831.
41. Guesdon B., Paradis E., Samson P., Richard D. Effects of intracerebroventricular and intra-accumbens melanin-concentrating hormone agonism on food intake and energy expenditure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R469-R475.
42. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
43. Hayashi K., Shirao T. Change in the shape of dendritic spines caused by overexpression of drebrin in cultured cortical neurons. J. Neurosci. 1999, 19:3918-3925.
44. Holtzman A., Simon E.W. Body temperature as a risk factor for Alzheimer's disease. Med. Hypotheses 2000, 55:440-444.
45. Honer W.G., Dickson D.W., Gleeson J., Davies P. Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging 1992, 13:375-382.
46. Huitron-Resendiz S., Sanchez-Alavez M., Gallegos R., Berg G., Crawford E., Giacchino J.L., Games D., Henriksen S.J., Criado J.R. Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res. 2002, 928:126-137.
47. Hyman B.T., Phelps C.H., Beach T.G., Bigio E.H., Cairns N.J., Carrillo M.C., Dickson D.W., Duyckaerts C., Frosch M.P., Masliah E., Mirra S.S., Nelson P.T., Schneider J.A., Thal D.R., Thies B., Trojanowski J.Q., Vinters H.V., Montine T.J. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 2012, 8:1-13.
48. Julien C., Bretteville A., Planel E. Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies. Methods Mol. Biol. 2012, 849:473-491.
49. Julien C., Tremblay C., Bendjelloul F., Phivilay A., Coulombe M.A., Emond V., Calon F. Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathology. J. Neurosci. Res. 2008, 86:2292-2302.
50. Kandasamy A.D., Sung M.M., Boisvenue J.J., Barr A.J., Dyck J.R. Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice. Nutr. Diabetes 2012, 2:e45.
51. Karp C.L. Unstressing intemperate models: how cold stress undermines mouse modeling. J. Exp. Med. 2012, 209:1069-1074.
52. Keller M.C., Fredrickson B.L., Ybarra O., Cote S., Johnson K., Mikels J., Conway A., Wager T. A warm heart and a clear head. The contingent effects of weather on mood and cognition. Psychol. Sci. 2005, 16:724-731.
53. Kojima N., Shirao T. Synaptic dysfunction and disruption of postsynaptic drebrin-actin complex: a study of neurological disorders accompanied by cognitive deficits. Neurosci. Res. 2007, 58:1-5.
54. Korneyev A., Binder L., Bernardis J. Rapid reversible phosphorylation of rat brain tau proteins in response to cold water stress. Neurosci. Lett. 1995, 191:19-22.
55. Korneyev A.Y. Stress-induced tau phosphorylation in mouse strains with different brain Erk 1 + 2 immunoreactivity. Neurochem. Res. 1998, 23:1539-1543.
56. Kumar-Singh S., Theuns J., Van Broeck B., Pirici D., Vennekens K., Corsmit E., Cruts M., Dermaut B., Wang R., Van Broeckhoven C. Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum. Mutat. 2006, 27:686-695.
57. Kusudo T., Wang Z., Mizuno A., Suzuki M., Yamashita H. TRPV4 deficiency increases skeletal muscle metabolic capacity and resistance against diet-induced obesity. J. Appl. Physiol. (1985) 2012, 112:1223-1232.
58. Latapy C., Rioux V., Guitton M.J., Beaulieu J.M. Selective deletion of forebrain glycogen synthase kinase 3beta reveals a central role in serotonin-sensitive anxiety and social behaviour. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2012, 367:2460-2474.
59. Lebbadi M., Julien C., Phivilay A., Tremblay C., Emond V., Kang J.X., Calon F. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease. J. Alzheimers Dis. 2011, 27:853-869.
60. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., Frosch M.P., Selkoe D.J. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 2003, 40:1087-1093.
61. Lenhardt R. The effect of anesthesia on body temperature control. Front. Biosci. (Schol. Ed.) 2010, 2:1145-1154.
62. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., Crowley A.C., Fu Y-H., Guenette S.Y., Galas D., Nemens E., Wijsman E.M., Bird T.D., Schellenberg G.D., Tanzi R.E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995, 269:973-977.
63. Li R., Singh M. Sex differences in cognitive impairment and Alzheimer's disease. Front. Neuroendocrinol. 2014, 35:385-403.
64. Lidell M.E., Enerback S. Brown adipose tissue-a new role in humans?. Nat. Rev. Endocrinol. 2010, 6:319-325.
65. Lowell B.B., Spiegelman B.M. Towards a molecular understanding of adaptive thermogenesis. Nature 2000, 404:652-660.
66. Loyd C., Obici S. Brown fat fuel use and regulation of energy homeostasis. Curr. Opin. Clin. Nutr. Metab. Care 2014, 17:368-372.
67. Martinez-Coria H., Green K.N., Billings L.M., Kitazawa M., Albrecht M., Rammes G., Parsons C.G., Gupta S., Banerjee P., LaFerla F.M. Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice. Am. J. Pathol. 2010, 176:870-880.
68. Maurin H., Lechat B., Borghgraef P., Devijver H., Jaworski T., VanLeuven F. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3alpha/beta. Eur J Neurosci 2014, 40:2442-2453.
69. Nagy Z.M., Anderson J.A., Mazzaferri T.A. Hypothermia causes adult-like retention deficits of prior learning in infant mice. Dev. Psychobiol. 1976, 9:447-458.
70. Nalivaeva N.N., Beckett C., Belyaev N.D., Turner A.J. Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?. J. Neurochem. 2012, 120 Suppl 1:167-185.
71. Nelson P.T., Alafuzoff I., Bigio E.H., Bouras C., Braak H., Cairns N.J., Castellani R.J., Crain B.J., Davies P., Del Tredici K., Duyckaerts C., Frosch M.P., Haroutunian V., Hof P.R., Hulette C.M., Hyman B.T., Iwatsubo T., Jellinger K.A., Jicha G.A., Kovari E., Kukull W.A., Leverenz J.B., Love S., Mackenzie I.R., Mann D.M., Masliah E., McKee A.C., Montine T.J., Morris J.C., Schneider J.A., Sonnen J.A., Thal D.R., Trojanowski J.Q., Troncoso J.C., Wisniewski T., Woltjer R.L., Beach T.G. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J. Neuropathol. Exp. Neurol. 2012, 71:362-381.
72. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
73. Okawa M., Mishima K., Hishikawa Y., Hozumi S., Hori H., Takahashi K. Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep 1991, 14:478-485.
74. Padovani R., Lehnert T., Cettour-Rose P., Doenlen R., Auwerx J., Gijs M.A. Miniaturized implantable sensors for in vivo localized temperature measurements in mice during cold exposure. Biomed. Microdevices 2016, 18:1.
75. Papon M.A., El Khoury N.B., Marcouiller F., Julien C., Morin F., Bretteville A., Petry F.R., Gaudreau S., Amrani A., Mathews P.M., Hebert S.S., Planel E. Deregulation of protein phosphatase 2A and hyperphosphorylation of tau protein following onset of diabetes in NOD mice. Diabetes 2013, 62:609-617.
76. Planel E., Bretteville A., Liu L., Virag L., Du A.L., Yu W.H., Dickson D.W., Whittington R.A., Duff K.E. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. FASEB J. 2009, 23:2595-2604.
77. Planel E., Miyasaka T., Launey T., Chui D.H., Tanemura K., Sato S., Murayama O., Ishiguro K., Tatebayashi Y., Takashima A. Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J. Neurosci. 2004, 24:2401-2411.
78. Planel E., Tatebayashi Y., Miyasaka T., Liu L., Wang L., Herman M., Yu W.H., Luchsinger J.A., Wadzinski B., Duff K.E., Takashima A. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J. Neurosci. 2007, 27:13635-13648.
79. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N. Engl. J. Med. 2010, 362:329-344.
80. Richard D., Picard F. Brown fat biology and thermogenesis. Front. Biosci. (Landmark Ed.) 2011, 16:1233-1260.
81. Ridge P.G., Ebbert M.T., Kauwe J.S. Genetics of Alzheimer's disease. Biomed. Res. Int. 2013, 2013:254954.
82. Rizzo M.R., Mari D., Barbieri M., Ragno E., Grella R., Provenzano R., Villa I., Esposito K., Giugliano D., Paolisso G. Resting metabolic rate and respiratory quotient in human longevity. J. Clin. Endocrinol. Metab. 2005, 90:409-413.
83. Rocca W.A., Petersen R.C., Knopman D.S., Hebert L.E., Evans D.A., Hall K.S., Gao S., Unverzagt F.W., Langa K.M., Larson E.B., White L.R. Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement. 2011, 7:80-93.
84. Sagare A., Deane R., Bell R.D., Johnson B., Hamm K., Pendu R., Marky A., Lenting P.J., Wu Z., Zarcone T., Goate A., Mayo K., Perlmutter D., Coma M., Zhong Z., Zlokovic B.V. Clearance of amyloid-beta by circulating lipoprotein receptors. Nat. Med. 2007, 13:1029-1031.
85. Satlin A., Volicer L., Stopa E.G., Harper D. Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiol. Aging 1995, 16:765-771.
86. Schellenberg G.D., Montine T.J. The genetics and neuropathology of Alzheimer's disease. Acta Neuropathol. 2012, 124:305-323.
87. Selkoe D.J. The origins of Alzheimer disease: a is for amyloid. JAMA 2000, 283:1615-1617.
88. Sellaro R., Hommel B., Manai M., Colzato L.S. Preferred, but not objective temperature predicts working memory depletion. Psychol. Res. 2015, 79:282-288.
89. Shepherd C., McCann H., Halliday G.M. Variations in the neuropathology of familial Alzheimer's disease. Acta Neuropathol. 2009, 118:37-52.
90. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A., Haines J.L., Perkicak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375:754-760.
91. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., Holtzman D.M., Miller C.A., Strickland D.K., Ghiso J., Zlokovic B.V. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 2000, 106:1489-1499.
92. Shirao T. The roles of microfilament-associated proteins, drebrins, in brain morphogenesis: a review. J. Biochem. 1995, 117:231-236.
93. Simpson J., Yates C.M., Watts A.G., Fink G. Congo red birefringent structures in the hypothalamus in senile dementia of the Alzheimer type. Neuropathol. Appl. Neurobiol. 1988, 14:381-393.
94. Sorrentino P., Iuliano A., Polverino A., Jacini F., Sorrentino G. The dark sides of amyloid in Alzheimer's disease pathogenesis. FEBS Lett. 2014, 588:641-652.
95. St-Amour I., Pare I., Tremblay C., Coulombe K., Bazin R., Calon F. IVIg protects the 3xTg-AD mouse model of Alzheimer's disease from memory deficit and Abeta pathology. J. Neuroinflammation 2014, 11:54.
96. Sze C.I., Troncoso J.C., Kawas C., Mouton P., Price D.L., Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol. 1997, 56:933-944.
97. Tan W., Cao X., Wang J., Lv H., Wu B., Ma H. Tau hyperphosphorylation is associated with memory impairment after exposure to 1.5% isoflurane without temperature maintenance in rats. Eur. J. Anaesthesiol. 2010, 27:835-841.
98. Tao G., Zhang J., Zhang L., Dong Y., Yu B., Crosby G., Culley D.J., Zhang Y., Xie Z. Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3beta activation in young mice. Anesthesiology 2014, 121:510-527.
99. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
100. Touitou Y., Reinberg A., Bogdan A., Auzeby A., Beck H., Touitou C. Age-related changes in both circadian and seasonal rhythms of rectal temperature with special reference to senile dementia of Alzheimer type. Gerontology 1986, 32:110-118.
101. Tremblay C., Pilote M., Phivilay A., Emond V., Bennett D.A., Calon F. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease. J. Alzheimers Dis. 2007, 12:377-390.
102. van de Nes J.A., Konermann S., Nafe R., Swaab D.F. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients. Acta Neuropathol. 2006, 111:126-138.
103. Wakabayashi K., Honer W.G., Masliah E. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease. Brain Res. 1994, 667:24-32.
104. Weinert D. Circadian temperature variation and ageing. Ageing Res. Rev. 2010, 9:51-60.
105. Whittington R.A., Bretteville A., Dickler M.F., Planel E. Anesthesia and tau pathology. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 47:147-155.
106. Ye L., Kleiner S., Wu J., Sah R., Gupta R.K., Banks A.S., Cohen P., Khandekar M.J., Bostrom P., Mepani R.J., Laznik D., Kamenecka T.M., Song X., Liedtke W., Mootha V.K., Puigserver P., Griffin P.R., Clapham D.E., Spiegelman B.M. TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis. Cell 2012, 151:96-110.
107. Ziegler-Graham K., Brookmeyer R., Johnson E., Arrighi H.M. Worldwide variation in the doubling time of Alzheimer's disease incidence rates. Alzheimers Dement. 2008, 4:316-323.
108. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 2011, 12:723-738.
109. Zlokovic B.V., Deane R., Sagare A.P., Bell R.D., Winkler E.A. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta-peptide elimination from the brain. J. Neurochem. 2010, 115:1077-1089.